首页|Impact of pancreatic and biliary stent on post-endoscopic papillectomy complications:A single-center retrospective study

Impact of pancreatic and biliary stent on post-endoscopic papillectomy complications:A single-center retrospective study

扫码查看
Background:Endoscopic papillectomy(EP)is recommended as the first-line therapy for ampullary tumors,despite a relatively high incidence of complications.Pancreatic and/or biliary stents are placed at the endoscopist's discretion to prevent post-EP complications.The present study aimed to evaluate the efficacy of different stents.Methods:A total of 117 patients who underwent EP and met the criteria between June 2006 and October 2022 were enrolled in the study.These patients were divided into a pancreatic stent group(PS group,n=47),a biliary stent group(BS group,n=38),and a two-stent group(PBS[PS and BS]group,n=32).Relevant clinical data were collected and compared among the three groups.Multivariate logistic analyses were performed to explore risk factors for post-EP complications.Results:The incidence of all complications was 37.6%(44/117).Pancreatitis and hemorrhage were the two most common complications with incidence rates of 14.5%(17/117)and 17.9%(21/117).The incidence rates of post-EP pancreatitis were 10.6%(5/47),23.7%(9/38),and 9.4%(3/32)in the PS group,BS group,and PBS group,respectively,with no significant differences.There were also no significant differences in other complications among the three groups.Age(odds ratio[OR]:0.95;95%confidence interval[CI]:0.91-0.99;P=0.022)was independently associated with post-EP pancreatitis while tumor size(OR:1.66;95%CI:1.06-2.60;P=0.028)was independently associated with post-EP hemorrhage.Conclusions:While pancreatic stenting is the first choice to prevent post-EP pancreatitis,biliary stenting could also be considered as a substitute for patients with difficulties in pancreatic cannulation.Two-stent(biliary and pancreatic stent)placement is unnecessary unless it is required due to other concerns.

Endoscopic papillectomyComplicationsPreventive measuresPancreatitisHemorrhage

Nan Ru、Ningli Chai、Bo Zhang、Longsong Li、Yawei Bi、Enqiang Linghu

展开 >

Department of Gastroenterology,The First Medical Center of Chinese People's Liberation Army General Hospital,Beijing 100853,China

Digestive Endoscopy Center,The First Medical Center of Chinese People's Liberation Army General Hospital,Beijing 100853,China

2024

中华医学杂志(英文版)
中华医学会

中华医学杂志(英文版)

CSTPCD
影响因子:0.838
ISSN:0366-6999
年,卷(期):2024.137(17)